Valneva, A French Vaccines Firm To Sell 8.1% Share To Pfizer
Pfizer, the world's largest pharmaceutical company, has decided to invest 90.5 million euros ($95.24 million) in Valneva, a French vaccine company, as the businesses...
Australia Grants $143.3mn To Sydney Biomedical Accelerator
The University of Sydney has revealed that the New South Wales (NSW) state will contribute $143.3 million over four years to the construction of...
Third Rock Ventures $1 Billion Fund To Aid Biotech Startups
Third Rock Ventures, a well-known funder of biotech startups, announced the closure of a billion-dollar fund recently that would be used to create and grow...
Alzheimers Disease Can Be Diagnosed By A Single Brain Scan
Doctors currently use a variety of tests to identify Alzheimer's disease, including memory and cognitive tests that can take several weeks to set up...
U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers
The first COVID-19 vaccines for newborns and preschoolers were approved by US regulators on Friday, June 17, paving the path for inoculation to begin...
Chronic Pain Gene Discovered By The University Of Oxford
The University of Oxford in the United Kingdom has discovered a gene that controls pain sensitivity by enhancing pain impulses in the spinal cord.
This...
Rising Insulin Costs Compel FTC To Target Drugmakers And PBM
Bribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US regulators, with a particular focus on rising insulin prices....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...